John Dulos
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Rheumatology top 10%
- Rheumatoid Arthritis Research and Therapies
Papers in
- Rheumatology 10
- Rheumatoid Arthritis Research and Therapies 10
-
- Renal Diseases and Glomerulopathies 2
- Co-authors
- Annemieke M. H. Boots (11 shared papers)Hans van Eenennaam (6 shared papers)Willemijn A. Hobo (1 shared paper)Cornelis J.A. Punt (1 shared paper)Anton F. J. de Haan (1 shared paper)Joannes F.M. Jacobs (1 shared paper)Egbert Oosterwijk (1 shared paper)Gregory J. Carven (1 shared paper)
- Journals
- Arthritis Research & Therapy (2 papers)Blood (1 paper)Science Translational Medicine (1 paper)Molecular Cancer Therapeutics (1 paper)British Journal of Pharmacology (1 paper)
- Partner nations
- NetherlandsUnited StatesAustralia
In The Last Decade
John Dulos
21 papers receiving 737 citations
Peers
Comparison fields: 5 of 66
- Oncology 230
- Rheumatology 94
- Immunology 114
- Physiology 17
- Hematology 46
Countries citing papers authored by John Dulos
This map shows the geographic impact of John Dulos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Dulos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Dulos more than expected).
Fields of papers citing papers by John Dulos
This network shows the impact of papers produced by John Dulos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Dulos. The network helps show where John Dulos may publish in the future.
Co-authors
The 25 scholars most cited alongside John Dulos, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 285 | |
| 2 | 2018 | 75 | |
| 3 | 2008 | 48 | |
| 4 | 2005 | 46 | |
| 5 | 2009 | 37 | |
| 6 | 2004 | 36 | |
| 7 | 2018 | 33 | |
| 8 | 2010 | 28 | |
| 9 | 2011 | 26 | |
| 10 | Origin of primordial germ cells, as characterized by the presence of nuage, in embryos of the teleost fish Barbus conchonius. | 1992 | 19 |
| 11 | 2011 | 18 | |
| 12 | 2025 | 18 | |
| 13 | 2005 | 17 | |
| 14 | 2020 | 17 | |
| 15 | 2012 | 16 | |
| 16 | p38 inhibition and not MK2 inhibition enhances the secretion of chemokines from TNF-α activated rheumatoid arthritis fibroblast-like synoviocytes. | 2013 | 16 |
| 17 | 2006 | 13 | |
| 18 | 1992 | 8 | |
| 19 | A selective estrogen receptor alpha agonist (ORG 37663) suppresses inflammation and arthritis in mouse models | 2006 | 3 |
| 20 | 2016 | 2 |
About John Dulos
John Dulos is a scholar working on Rheumatology, Nephrology, Hematology, Immunology and Molecular Biology, having authored 23 papers that have together received 763 indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (10 papers), Cancer Immunotherapy and Biomarkers (2 papers), Estrogen and related hormone effects (2 papers), Renal Diseases and Glomerulopathies (2 papers), Developmental Biology and Gene Regulation (2 papers), Multiple Myeloma Research and Treatments (2 papers), Muscle Physiology and Disorders (2 papers) and Synthesis and biological activity (1 paper). The work is most often cited by research in Oncology (230 citations), Rheumatology (94 citations), Immunology (114 citations), Physiology (17 citations) and Hematology (46 citations). John Dulos has collaborated with scholars based in Netherlands, United States and Australia. Frequent co-authors include Annemieke M. H. Boots, Hans van Eenennaam, Willemijn A. Hobo, Cornelis J.A. Punt, Anton F. J. de Haan, Joannes F.M. Jacobs, Egbert Oosterwijk, Gregory J. Carven, Peter Mulders and Jack A. Schalken. Their work appears in journals such as Arthritis Research & Therapy, Blood, Science Translational Medicine, Molecular Cancer Therapeutics and British Journal of Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.